Boston Trust Walden Corp cut its position in Plexus Corp. (NASDAQ:PLXS - Free Report) by 1.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 378,248 shares of the technology company's stock after selling 6,036 shares during the quarter. Boston Trust Walden Corp owned about 1.40% of Plexus worth $48,465,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC purchased a new position in Plexus during the fourth quarter worth about $783,000. Principal Financial Group Inc. boosted its holdings in shares of Plexus by 3.3% in the 4th quarter. Principal Financial Group Inc. now owns 138,367 shares of the technology company's stock worth $21,652,000 after purchasing an additional 4,445 shares in the last quarter. Handelsbanken Fonder AB boosted its holdings in shares of Plexus by 11.2% in the 4th quarter. Handelsbanken Fonder AB now owns 6,937 shares of the technology company's stock worth $1,086,000 after purchasing an additional 700 shares in the last quarter. Olympiad Research LP purchased a new position in shares of Plexus in the 4th quarter worth about $322,000. Finally, Proficio Capital Partners LLC purchased a new position in shares of Plexus in the 4th quarter worth about $2,277,000. 94.45% of the stock is currently owned by institutional investors.
Plexus Trading Up 0.0%
PLXS opened at $130.86 on Friday. The business has a 50 day simple moving average of $128.73 and a two-hundred day simple moving average of $138.69. The firm has a market capitalization of $3.54 billion, a price-to-earnings ratio of 25.46 and a beta of 0.81. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.71. Plexus Corp. has a one year low of $100.96 and a one year high of $172.89.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.12. Plexus had a return on equity of 11.17% and a net margin of 3.60%. The firm had revenue of $980.17 million during the quarter, compared to analyst estimates of $980.07 million. During the same quarter in the prior year, the company earned $0.94 EPS. The business's revenue was up 1.4% compared to the same quarter last year. Analysts predict that Plexus Corp. will post 5.9 EPS for the current year.
Analyst Upgrades and Downgrades
PLXS has been the subject of a number of research reports. Wall Street Zen upgraded Plexus from a "buy" rating to a "strong-buy" rating in a report on Saturday, June 14th. Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Plexus in a research report on Wednesday, June 4th. Stifel Nicolaus set a $145.00 price target on Plexus in a research report on Thursday, April 24th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $162.00 price target (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Plexus presently has a consensus rating of "Moderate Buy" and an average price target of $155.67.
Get Our Latest Research Report on Plexus
Insider Transactions at Plexus
In other news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $129.87, for a total value of $194,805.00. Following the completion of the transaction, the chief executive officer now owns 75,214 shares of the company's stock, valued at approximately $9,768,042.18. This represents a 1.96% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Angelo Michael Ninivaggi, Jr. sold 2,058 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $132.22, for a total value of $272,108.76. Following the completion of the transaction, the chief accounting officer now directly owns 26,133 shares of the company's stock, valued at $3,455,305.26. This represents a 7.30% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,032 shares of company stock valued at $1,582,222. Corporate insiders own 1.76% of the company's stock.
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.